Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

Overview of attention for article published in The Lancet HIV, March 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 17 news outlets
blogs: 1 blog

twitter: 6 X users
patent: 1 patent

Readers on

mendeley: 181 Mendeley

So far, Altmetric has seen 17 news stories from 17 outlets.

mRNA technology for the prevention and treatment of HIV-1 infection

Raw News Health, 09 Jan 2026

Bekker, L.

Longer-lasting HIV antibody treatments could offer a one-shot alternative to maintenance therapies

MedicalXpress, 26 Sep 2022

Credit: Unsplash/CC0 Public Domain Antiretroviral therapy has had an enormous impact on treating HIV infections around the world.

Insiders fear Letitia James is set to inflict 'the biggest political damage' to Trump with GOP voters: report

The Raw Story, 23 Sep 2022

HIV poses a challenge to the immune system. HIV presents challenges to antibodies Antibodies are proteins that serve as major…

HIV therapies currently need to be taken regularly for life – longer-lasting antibody treatments could one day offer an equally effective one-shot alternative - News Azi

News Azi, 23 Sep 2022

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 13 additional news stories.